Our top pick for
GoHealth, Inc is an insurance brokers business based in the US. GoHealth shares (GOCO) are listed on the NASDAQ and all prices are listed in US Dollars. GoHealth employs 1,892 staff and has a trailing 12-month revenue of around USD$664 million.
|Latest market close||USD$12.06|
|52-week range||USD$11.55 - USD$26.25|
|50-day moving average||USD$13.409|
|200-day moving average||USD$15.5772|
|Wall St. target price||USD$22.6|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.1499|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-18)||2.38%|
|1 month (2020-10-26)||7.10%|
|3 months (2020-08-25)||-15.66%|
|6 months (2020-05-22)||N/A|
|1 year (2019-11-22)||N/A|
|2 years (2018-11-23)||7,940.00%|
|3 years (2017-11-24)||-86.53%|
|5 years (2015-11-22)||N/A|
Valuing GoHealth stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of GoHealth's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
GoHealth's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$91.1 million.
The EBITDA is a measure of a GoHealth's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$664 million|
|Operating margin TTM||5.54%|
|Gross profit TTM||USD$369.9 million|
|Return on assets TTM||0%|
|Return on equity TTM||0%|
|Market capitalisation||USD$3.7 billion|
TTM: trailing 12 months
There are currently 4.2 million GoHealth shares held short by investors – that's known as GoHealth's "short interest". This figure is 48.1% up from 2.9 million last month.
There are a few different ways that this level of interest in shorting GoHealth shares can be evaluated.
GoHealth's "short interest ratio" (SIR) is the quantity of GoHealth shares currently shorted divided by the average quantity of GoHealth shares traded daily (recently around 1.1 million). GoHealth's SIR currently stands at 3.7. In other words for every 100,000 GoHealth shares traded daily on the market, roughly 3700 shares are currently held short.
However GoHealth's short interest can also be evaluated against the total number of GoHealth shares, or, against the total number of tradable GoHealth shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case GoHealth's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 GoHealth shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable GoHealth shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against GoHealth.
Find out more about how you can short GoHealth stock.
We're not expecting GoHealth to pay a dividend over the next 12 months.
GoHealth, Inc. operates a health insurance marketplace to enhance access to healthcare in the United States. The company, through its platform, offer various health insurance policies, including Medicare advantage, Medicare supplement, Medicare prescription drug plans, and Medicare special needs plans; and individual and family, dental, vision, and other related plans. The company was founded in 2001 and is headquartered in Chicago, Illinois.
Everything we know about the Qilian International Holding Group IPO, plus information on how to buy in.
Everything we know about the AbCellera Biologics IPO, plus information on how to buy in.
Steps to owning and managing CALM, with 24-hour and historical pricing before you buy.
Steps to owning and managing CRR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BG, with 24-hour and historical pricing before you buy.
Steps to owning and managing BCLI, with 24-hour and historical pricing before you buy.
Steps to owning and managing BLBD, with 24-hour and historical pricing before you buy.
Steps to owning and managing BDTX, with 24-hour and historical pricing before you buy.
Steps to owning and managing RILYO, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASPN, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.